M 1st Invitation to manufacturers of Mycobacterium tuberculosis antigen-based skin tests (TBSTs) to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit PDF Guideline/guidance
IVD Protocol for evaluation of Nucleic acid tests for detection of drug resistance in Mycobacterium tuberculosis complex Guideline/guidance
M 10th Invitation to manufacturers of reproductive health products to submit an expression of interest (EOI) for product evaluation to the WHO Prequalification Team: medicines PDF Guideline/guidance
M 11th Invitation for Expression of Interest (EOI) for antimalarial medicines published Guideline/guidance
IVD 1st Invitation to laboratories to submit an expression of interest (23 May 2016) PDF Guideline/guidance
M 1st Invitation to Manufacturers of Biotherapeutic Products (BTPs) and Similar Biotherapeutic Products (SBPs)to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Team - Biotherapeutic Products (BTPs) PDF Guideline/guidance
IVD 1st Invitation to manufacturers of IVDs medical devices used for the qualitative detection of Mycobacterium tuberculosis complex DNA and mutations associated with drug-resistant tuberculosis to apply for WHO prequalification assessment as of 22 September PDF
M 1st Invitation to manufacturers of medicinal products for treatment of Apnoea in Preterm infants to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit PDF Guideline/guidance
M 1st Invitation to manufacturers of medicinal products for treatment of bacterial infections in children to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit PDF Guideline/guidance
M 1st Invitation to manufacturers of medicinal products for treatment of disorders caused by use of tobacco, to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit PDF Guideline/guidance
M 1st Invitation to manufacturers of medicinal products for treatment of infections in newborn and young infants and childhood pneumonia, to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit PDF Guideline/guidance
M 1st Invitation to manufacturers of medicinal products for treatment of multi-drug resistant bacterial infections, to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit PDF Guideline/guidance
ID IVD IS M V VCP 2023 Joint UNICEF-UNFPA-WHO Meeting - Aligning WHO Normative and Prequalification Processes PDF Presentation
ID IVD IS M V VCP 2023 Joint UNICEF-UNFPA-WHO Meeting - Aligning WHO Normative and Prequalification Processes PDF Presentation
ID IVD IS M V VCP 2023 Joint UNICEF-UNFPA-WHO Meeting - Aligning WHO Normative and Prequalification Processes PDF Presentation
ID IVD IS M V VCP 2023 Joint UNICEF-UNFPA-WHO Meeting - Aligning WHO Normative and Prequalification Processes PDF Presentation
ID IVD IS M V VCP 2023 Joint UNICEF-UNFPA-WHO Meeting - Aligning WHO Normative and Prequalification Processes PDF Presentation
ID IVD IS M V VCP 2023 Joint UNICEF-UNFPA-WHO Meeting - Aligning WHO Normative and Prequalification Processes PDF Presentation
ID IVD IS M V VCP 2023 Joint UNICEF-UNFPA-WHO Meeting - Update and progress on the Coordinated Scientific Advice (CSA) PDF Presentation
ID IVD IS M V VCP 2023 Joint UNICEF-UNFPA-WHO Meeting - Update and progress on the Coordinated Scientific Advice (CSA) PDF Presentation
ID IVD IS M V VCP 2023 Joint UNICEF-UNFPA-WHO Meeting - Update and progress on the Coordinated Scientific Advice (CSA) PDF Presentation
ID IVD IS M V VCP 2023 Joint UNICEF-UNFPA-WHO Meeting - Update and progress on the Coordinated Scientific Advice (CSA) PDF Presentation
ID IVD IS M V VCP 2023 Joint UNICEF-UNFPA-WHO Meeting - Update and progress on the Coordinated Scientific Advice (CSA) PDF Presentation
ID IVD IS M V VCP 2023 Joint UNICEF-UNFPA-WHO Meeting - Update and progress on the Coordinated Scientific Advice (CSA) PDF Presentation
M 21st Invitation for Expression of Interest (EOI) for medicines against HIV infection and related diseases to submit an expression of interest (EOI) for product evaluation to the WHO Prequalification Unit Guideline/guidance